Published in J Clin Invest on May 08, 2012
Thrombosis as an intravascular effector of innate immunity. Nat Rev Immunol (2012) 2.98
Nontoxic polyphosphate inhibitors reduce thrombosis while sparing hemostasis. Blood (2014) 1.55
Synergies of phosphatidylserine and protein disulfide isomerase in tissue factor activation. Thromb Haemost (2014) 1.29
Rapid activation of monocyte tissue factor by antithymocyte globulin is dependent on complement and protein disulfide isomerase. Blood (2013) 1.07
Defective PDI release from platelets and endothelial cells impairs thrombus formation in Hermansky-Pudlak syndrome. Blood (2015) 1.06
Platelets are required for enhanced activation of the endothelium and fibrinogen in a mouse thrombosis model of APS. Blood (2014) 0.99
Thiol isomerases in thrombus formation. Circ Res (2014) 0.96
Protein disulfide isomerase a multifunctional protein with multiple physiological roles. Front Chem (2014) 0.96
Control of blood proteins by functional disulfide bonds. Blood (2014) 0.94
Therapeutic implications of protein disulfide isomerase inhibition in thrombotic disease. Arterioscler Thromb Vasc Biol (2014) 0.94
Nox NADPH oxidases and the endoplasmic reticulum. Antioxid Redox Signal (2014) 0.94
Dynamin-related protein-1 controls fusion pore dynamics during platelet granule exocytosis. Arterioscler Thromb Vasc Biol (2013) 0.91
Both platelet- and endothelial cell-derived ERp5 support thrombus formation in a laser-induced mouse model of thrombosis. Blood (2015) 0.91
The C-terminal CGHC motif of protein disulfide isomerase supports thrombosis. J Clin Invest (2015) 0.85
Protein disulfide isomerase as an antithrombotic target. Trends Cardiovasc Med (2013) 0.83
Anti-Proliferative Effects of Rutin on OLETF Rat Vascular Smooth Muscle Cells Stimulated by Glucose Variability. Yonsei Med J (2016) 0.83
Extracellular Thiol Isomerases and Their Role in Thrombus Formation. Antioxid Redox Signal (2015) 0.82
Small molecule-induced oxidation of protein disulfide isomerase is neuroprotective. Proc Natl Acad Sci U S A (2015) 0.82
Broad-spectrum antivirals against viral fusion. Nat Rev Microbiol (2015) 0.82
A substrate-driven allosteric switch that enhances PDI catalytic activity. Nat Commun (2016) 0.81
Novel roles for protein disulphide isomerase in disease states: a double edged sword? Front Cell Dev Biol (2015) 0.81
Quercetin-3-rutinoside Inhibits Protein Disulfide Isomerase by Binding to Its b'x Domain. J Biol Chem (2015) 0.80
VAMP-7 links granule exocytosis to actin reorganization during platelet activation. Blood (2015) 0.80
Complement-Coagulation Cross-Talk: A Potential Mediator of the Physiological Activation of Complement by Low pH. Front Immunol (2015) 0.79
The dehydrogenase region of the NADPH oxidase component Nox2 acts as a protein disulfide isomerase (PDI) resembling PDIA3 with a role in the binding of the activator protein p67 (phox.). Front Chem (2015) 0.79
Novel anti-thrombotic agent for modulation of protein disulfide isomerase family member ERp57 for prophylactic therapy. Sci Rep (2015) 0.79
Analysis of the isomerase and chaperone-like activities of an amebic PDI (EhPDI). Biomed Res Int (2015) 0.79
Vascular thiol isomerases. Blood (2016) 0.78
Targeted antithrombotic protein micelles. Angew Chem Int Ed Engl (2014) 0.77
Platelet-targeting thiol reduction sensor detects thiol isomerase activity on activated platelets in mouse and human blood under flow. J Thromb Haemost (2016) 0.77
Methods of measuring protein disulfide isomerase activity: a critical overview. Front Chem (2014) 0.77
Mia40 is a facile oxidant of unfolded reduced proteins but shows minimal isomerase activity. Arch Biochem Biophys (2015) 0.76
An arsenical-maleimide for the generation of new targeted biochemical reagents. J Am Chem Soc (2013) 0.76
The integrin PSI domain has an endogenous thiol isomerase function and is a novel target for antiplatelet therapy. Blood (2017) 0.75
Revisiting the mechanistic basis of the French Paradox: Red wine inhibits the activity of protein disulfide isomerase in vitro. Thromb Res (2015) 0.75
A specific plasminogen activator inhibitor-1 antagonist derived from inactivated urokinase. J Cell Mol Med (2016) 0.75
Protein disulfide isomerase secretion following vascular injury initiates a regulatory pathway for thrombus formation. Nat Commun (2017) 0.75
Thioredoxin Inhibitors Attenuate Platelet Function and Thrombus Formation. PLoS One (2016) 0.75
Treatment of Thrombotic Antiphospholipid Syndrome: The Rationale of Current Management-An Insight into Future Approaches. J Immunol Res (2015) 0.75
Protein disulfide isomerase inhibition blocks thrombin generation in humans by interfering with platelet factor V activation. JCI Insight (2017) 0.75
An ERp57-mediated disulphide exchange promotes the interaction between Burkholderia cenocepacia and epithelial respiratory cells. Sci Rep (2016) 0.75
Golgi-independent routes support protein disulfide isomerase externalization in vascular smooth muscle cells. Redox Biol (2017) 0.75
Fruitflow(®): the first European Food Safety Authority-approved natural cardio-protective functional ingredient. Eur J Nutr (2016) 0.75
HPW-RX40 prevents human platelet activation by attenuating cell surface protein disulfide isomerases. Redox Biol (2017) 0.75
A new strategy for development of anti-thrombotic agents: inhibition of the C-terminal active site of PDI. J Thromb Haemost (2017) 0.75
Nitric Oxide and Protein Disulfide Isomerase Explain the Complexities of Unfolded Protein Response Following Intra-hippocampal Aβ Injection. Cell Mol Neurobiol (2015) 0.75
Extracellular vesicles: how they interact with endothelium, potentially contributing to metastatic cancer cell implants. Clin Transl Med (2017) 0.75
Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study. Lancet (1993) 6.53
Real-time in vivo imaging of platelets, tissue factor and fibrin during arterial thrombus formation in the mouse. Nat Med (2002) 4.54
Protein disulfide isomerase: a critical evaluation of its function in disulfide bond formation. Antioxid Redox Signal (2009) 3.12
Disulfide isomerization switches tissue factor from coagulation to cell signaling. Proc Natl Acad Sci U S A (2006) 2.65
Protein disulfide isomerase acts as an injury response signal that enhances fibrin generation via tissue factor activation. J Clin Invest (2008) 2.39
Dietary flavonoids, antioxidant vitamins, and incidence of stroke: the Zutphen study. Arch Intern Med (1996) 2.30
A critical role for extracellular protein disulfide isomerase during thrombus formation in mice. J Clin Invest (2008) 2.26
A critical review of the data related to the safety of quercetin and lack of evidence of in vivo toxicity, including lack of genotoxic/carcinogenic properties. Food Chem Toxicol (2007) 2.21
Redox regulation facilitates optimal peptide selection by MHC class I during antigen processing. Cell (2006) 2.20
Evidence for activation of tissue factor by an allosteric disulfide bond. Biochemistry (2006) 1.99
Par4 is required for platelet thrombus propagation but not fibrin generation in a mouse model of thrombosis. Proc Natl Acad Sci U S A (2006) 1.95
Monoclonal antibodies to a synthetic fibrin-like peptide bind to human fibrin but not fibrinogen. Science (1983) 1.89
Inhibition of a reductive function of the plasma membrane by bacitracin and antibodies against protein disulfide-isomerase. Proc Natl Acad Sci U S A (1993) 1.71
Enzymatically catalyzed disulfide exchange is required for platelet adhesion to collagen via integrin alpha2beta1. Blood (2003) 1.62
The relation between dietary flavonol intake and coronary heart disease mortality: a meta-analysis of prospective cohort studies. Eur J Clin Nutr (2003) 1.61
Increasing melanoma cell death using inhibitors of protein disulfide isomerases to abrogate survival responses to endoplasmic reticulum stress. Cancer Res (2008) 1.50
Cell-surface protein disulfide isomerase catalyzes transnitrosation and regulates intracellular transfer of nitric oxide. J Clin Invest (1999) 1.49
Protein disulfide isomerase and sulfhydryl-dependent pathways in platelet activation. Biochemistry (2001) 1.43
Endothelium-derived but not platelet-derived protein disulfide isomerase is required for thrombus formation in vivo. Blood (2010) 1.43
Physical proximity and functional association of glycoprotein 1balpha and protein-disulfide isomerase on the platelet plasma membrane. J Biol Chem (2000) 1.39
P2X7 receptor signaling contributes to tissue factor-dependent thrombosis in mice. J Clin Invest (2011) 1.29
Thrombus formation: direct real-time observation and digital analysis of thrombus assembly in a living mouse by confocal and widefield intravital microscopy. J Thromb Haemost (2003) 1.28
Allosteric disulfide bonds in thrombosis and thrombolysis. J Thromb Haemost (2006) 1.24
Protein disulphide isomerase mediates platelet aggregation and secretion. Br J Haematol (1999) 1.24
Protein disulfide isomerase mediates integrin-dependent adhesion. FEBS Lett (2000) 1.21
Platelets release novel thiol isomerase enzymes which are recruited to the cell surface following activation. Br J Haematol (2009) 1.21
Chlorogenic acid, quercetin-3-rutinoside and black tea phenols are extensively metabolized in humans. J Nutr (2003) 1.16
Characterization of redox state and reductase activity of protein disulfide isomerase under different redox environments using a sensitive fluorescent assay. Free Radic Biol Med (2007) 1.15
Laser-induced endothelial cell activation supports fibrin formation. Blood (2010) 1.12
Interaction and functional association of protein disulfide isomerase with alphaVbeta3 integrin on endothelial cells. FEBS J (2008) 1.09
Imaging fibrin formation and platelet and endothelial cell activation in vivo. Thromb Haemost (2011) 1.07
Exposure of the cryptic Arg-Gly-Asp sequence in thrombospondin-1 by protein disulfide isomerase. Biochim Biophys Acta (1998) 1.06
Sulfhydryl regulation of L-selectin shedding: phenylarsine oxide promotes activation-independent L-selectin shedding from leukocytes. J Immunol (2000) 1.05
Dietary administration of high doses of pterostilbene and quercetin to mice is not toxic. J Agric Food Chem (2009) 1.03
Protein disulphide isomerase in platelet function. Br J Haematol (2007) 1.02
Intestinal transport of quercetin glycosides in rats involves both deglycosylation and interaction with the hexose transport pathway. J Nutr (2000) 0.99
A high-throughput turbidometric assay for screening inhibitors of protein disulfide isomerase activity. J Biomol Screen (2004) 0.98
Bacitracin is not a specific inhibitor of protein disulfide isomerase. FEBS J (2010) 0.95
Bacitracin inhibits the reductive activity of protein disulfide isomerase by disulfide bond formation with free cysteines in the substrate-binding domain. FEBS J (2011) 0.93
Discovery of a small molecule PDI inhibitor that inhibits reduction of HIV-1 envelope glycoprotein gp120. ACS Chem Biol (2011) 0.92
Pharmacokinetics and metabolism of oral diosmin in healthy volunteers. Int J Clin Pharmacol Ther Toxicol (1992) 0.92
Protein disulfide isomerase knockdown-induced cell death is cell-line-dependent and involves apoptosis in MCF-7 cells. J Toxicol Sci (2011) 0.92
Role of dietary flavonoids in protection against cancer and coronary heart disease. Biochem Soc Trans (1996) 0.91
Anti-platelet effects of flavonoids and flavonoid-glycosides from Sophora japonica. Arch Pharm Res (2008) 0.89
Mechanisms involved in the antiplatelet activity of rutin, a glycoside of the flavonol quercetin, in human platelets. J Agric Food Chem (2004) 0.88
Absorption of quercetin and rutin in rat small intestine. Ann Nutr Metab (2005) 0.87
Uptake and localisation of O-(beta-hydroxyethyl)-rutosides in the venous wall, measured by laser scanning microscopy. Eur J Clin Pharmacol (1992) 0.84
The affinity of troxerutin for the venous wall measured by laser scanning microscopy. J Cardiovasc Surg (Torino) (1995) 0.78
Gene-expression profiles predict survival of patients with lung adenocarcinoma. Nat Med (2002) 21.28
SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas. Nat Genet (2009) 7.48
Mechanisms of thrombus formation. N Engl J Med (2008) 4.67
Real-time in vivo imaging of platelets, tissue factor and fibrin during arterial thrombus formation in the mouse. Nat Med (2002) 4.54
Exome and whole-genome sequencing of esophageal adenocarcinoma identifies recurrent driver events and mutational complexity. Nat Genet (2013) 4.48
Accumulation of tissue factor into developing thrombi in vivo is dependent upon microparticle P-selectin glycoprotein ligand 1 and platelet P-selectin. J Exp Med (2003) 3.61
Pleural effusions in hematologic malignancies. Chest (2004) 3.14
Verification and unmasking of widely used human esophageal adenocarcinoma cell lines. J Natl Cancer Inst (2010) 2.79
Platelet alpha-granules: basic biology and clinical correlates. Blood Rev (2009) 2.72
The iron chelator deferasirox protects mice from mucormycosis through iron starvation. J Clin Invest (2007) 2.48
Thrombus formation in vivo. J Clin Invest (2005) 2.38
ATGL has a key role in lipid droplet/adiposome degradation in mammalian cells. EMBO Rep (2006) 2.26
Gastrointestinal adenocarcinomas of the esophagus, stomach, and colon exhibit distinct patterns of genome instability and oncogenesis. Cancer Res (2012) 2.26
A critical role for extracellular protein disulfide isomerase during thrombus formation in mice. J Clin Invest (2008) 2.26
Hematopoietic cell-derived microparticle tissue factor contributes to fibrin formation during thrombus propagation. Blood (2004) 2.16
Intestinal microbes affect phenotypes and functions of invariant natural killer T cells in mice. Gastroenterology (2012) 2.11
Somatic single hits inactivate the X-linked tumor suppressor FOXP3 in the prostate. Cancer Cell (2009) 2.10
Glycoprotein VI-dependent and -independent pathways of thrombus formation in vivo. Blood (2006) 2.06
Tumor-derived tissue factor-bearing microparticles are associated with venous thromboembolic events in malignancy. Clin Cancer Res (2009) 2.04
Endobrevin/VAMP-8-dependent dense granule release mediates thrombus formation in vivo. Blood (2009) 2.00
Par4 is required for platelet thrombus propagation but not fibrin generation in a mouse model of thrombosis. Proc Natl Acad Sci U S A (2006) 1.95
Megakaryocyte-derived microparticles: direct visualization and distinction from platelet-derived microparticles. Blood (2008) 1.93
Crystal structure of human factor VIII: implications for the formation of the factor IXa-factor VIIIa complex. Structure (2008) 1.93
Mutations in NR5A1 associated with ovarian insufficiency. N Engl J Med (2009) 1.88
Structure of human urokinase plasminogen activator in complex with its receptor. Science (2006) 1.84
Expression analysis and genomic characterization of human melanoma differentiation associated gene-5, mda-5: a novel type I interferon-responsive apoptosis-inducing gene. Oncogene (2004) 1.83
The antifungal vaccine derived from the recombinant N terminus of Als3p protects mice against the bacterium Staphylococcus aureus. Infect Immun (2008) 1.77
Thrombin-initiated platelet activation in vivo is vWF independent during thrombus formation in a laser injury model. J Clin Invest (2007) 1.76
Draft genome of the kiwifruit Actinidia chinensis. Nat Commun (2013) 1.72
β₂-Glycoprotein-1 autoantibodies from patients with antiphospholipid syndrome are sufficient to potentiate arterial thrombus formation in a mouse model. Blood (2011) 1.69
Structural basis of membrane binding by Gla domains of vitamin K-dependent proteins. Nat Struct Biol (2003) 1.68
Nonclassic lipoid congenital adrenal hyperplasia masquerading as familial glucocorticoid deficiency. J Clin Endocrinol Metab (2009) 1.68
Two small GTPases act in concert with the bactofilin cytoskeleton to regulate dynamic bacterial cell polarity. Dev Cell (2013) 1.63
Gene amplification in esophageal adenocarcinomas and Barrett's with high-grade dysplasia. Clin Cancer Res (2003) 1.62
Platelets possess and require an active protein palmitoylation pathway for agonist-mediated activation and in vivo thrombus formation. Arterioscler Thromb Vasc Biol (2007) 1.56
Platelet PECAM-1 inhibits thrombus formation in vivo. Blood (2005) 1.53
Mutations in the p53 tumor suppressor gene and early onset breast cancer. Cancer Biol Ther (2002) 1.52
Monocyte tissue factor-dependent activation of coagulation in hypercholesterolemic mice and monkeys is inhibited by simvastatin. J Clin Invest (2012) 1.51
Assessment of ischemia-modified albumin levels for emergency room diagnosis of acute coronary syndrome. Int J Cardiol (2010) 1.49
PSGL-1 participates in E-selectin-mediated progenitor homing to bone marrow: evidence for cooperation between E-selectin ligands and alpha4 integrin. Blood (2003) 1.46
Leukocyte-versus microparticle-mediated tissue factor transfer during arteriolar thrombus development. J Leukoc Biol (2005) 1.46
Phosphorylated FADD induces NF-kappaB, perturbs cell cycle, and is associated with poor outcome in lung adenocarcinomas. Proc Natl Acad Sci U S A (2005) 1.44
Clinical relevance of microparticles from platelets and megakaryocytes. Curr Opin Hematol (2010) 1.43
Endothelium-derived but not platelet-derived protein disulfide isomerase is required for thrombus formation in vivo. Blood (2010) 1.43
DNA origami as a carrier for circumvention of drug resistance. J Am Chem Soc (2012) 1.42
Long noncoding RNAs in development and disease of the central nervous system. Trends Genet (2013) 1.42
miR-135a Suppresses Calcification in Senescent VSMCs by Regulating KLF4/STAT3 Pathway. Curr Vasc Pharmacol (2016) 1.42
Alpha 1,3 fucosyltransferases are master regulators of prostate cancer cell trafficking. Proc Natl Acad Sci U S A (2009) 1.40
Role of P-selectin and PSGL-1 in coagulation and thrombosis. Thromb Haemost (2004) 1.36
Hierarchical modeling for rare event detection and cell subset alignment across flow cytometry samples. PLoS Comput Biol (2013) 1.35
Human male infertility associated with mutations in NR5A1 encoding steroidogenic factor 1. Am J Hum Genet (2010) 1.35
Wild-type p53-induced phosphatase 1 dephosphorylates histone variant gamma-H2AX and suppresses DNA double strand break repair. J Biol Chem (2010) 1.34
PTP-1B is an essential positive regulator of platelet integrin signaling. J Cell Biol (2005) 1.34
Novel role of vitamin k in preventing oxidative injury to developing oligodendrocytes and neurons. J Neurosci (2003) 1.33
Active and passive immunization protects against lethal, extreme drug resistant-Acinetobacter baumannii infection. PLoS One (2012) 1.32
Levels of serum cytokines and acute phase proteins in patients with essential and cancer-related thrombocytosis. Am J Clin Oncol (2003) 1.32
NADPH oxidase contributes to renal damage and dysfunction in Dahl salt-sensitive hypertension. Am J Physiol Regul Integr Comp Physiol (2008) 1.31
Cell death in development: shaping the embryo. Histochem Cell Biol (2006) 1.30
DPP6 establishes the A-type K(+) current gradient critical for the regulation of dendritic excitability in CA1 hippocampal neurons. Neuron (2011) 1.30
Real-time assessment of cardiac perfusion, coronary angiography, and acute intravascular thrombi using dual-channel near-infrared fluorescence imaging. J Thorac Cardiovasc Surg (2009) 1.29
Steroidogenic factor-1 (SF-1, NR5A1) and human disease. Mol Cell Endocrinol (2010) 1.29
Type 1 ryanodine receptor in cardiac mitochondria: transducer of excitation-metabolism coupling. Biochim Biophys Acta (2005) 1.28
Expression and effect of inhibition of the ubiquitin-conjugating enzyme E2C on esophageal adenocarcinoma. Neoplasia (2006) 1.28
Mutational analysis of steroidogenic factor 1 (NR5a1) in 24 boys with bilateral anorchia: a French collaborative study. Hum Reprod (2007) 1.27
The high affinity iron permease is a key virulence factor required for Rhizopus oryzae pathogenesis. Mol Microbiol (2010) 1.27
Protein disulfide isomerase capture during thrombus formation in vivo depends on the presence of β3 integrins. Blood (2012) 1.26
The phosphatidylinositol 3-phosphate phosphatase myotubularin- related protein 6 (MTMR6) is a negative regulator of the Ca2+-activated K+ channel KCa3.1. Mol Cell Biol (2005) 1.26
Tubule-specific ablation of endogenous β-catenin aggravates acute kidney injury in mice. Kidney Int (2012) 1.25
Role of platelet P-selectin and microparticle PSGL-1 in thrombus formation. Trends Mol Med (2004) 1.24
Anaplastic large cell lymphoma involving the breast: a clinicopathologic study of 6 cases and review of the literature. Arch Pathol Lab Med (2009) 1.24
Crystal structures of two human vitronectin, urokinase and urokinase receptor complexes. Nat Struct Mol Biol (2008) 1.23